Efeito de um bioterápico 7DH de Toxoplasma gondii em camundongos infectados com o protozoário

Braga, Caroline Felicio; Drozino, Ricardo Nascimento; Moreira, Neide Martins; Aleixo, Denise Lessa; de Araújo, Silvana Marques.
Int. j. high dilution res ; 10(36): 147-151, september 30, 2011.
Artigo em Inglês | LILACS-Express | ID: hom-10716

Documentos relacionados

  1. Comparison of the immune response and protection against the experimental Toxoplasma gondii infection elicited by immunization with the recombinant proteins BAG1, ROP8, and BAG1-ROP8.
  2. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice.
  3. [Toxoplasma gondii-Current drugs and future vaccines against an underestimated protozoan infection].
  4. GRA8 DNA vaccine formulations protect against chronic toxoplasmosis.
  5. Genetic immunization against toxoplasmosis: A review article.
  6. Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB/c mice.
  7. Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis.
  8. Protective effect against toxoplasmosis in BALB/C mice vaccinated with recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine.
  9. Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection.
  10. The Molecular Characterization and Immunity Identification of Rhoptry Protein 22 of Toxoplasma gondii as a DNA Vaccine Candidate Against Toxoplasmosis.